The Role of SNHG15 in the Pathogenesis of Hepatocellular Carcinoma
- PMID: 35629174
- PMCID: PMC9145272
- DOI: 10.3390/jpm12050753
The Role of SNHG15 in the Pathogenesis of Hepatocellular Carcinoma
Abstract
Long non-coding RNAs (lncRNAs) are transcripts of more than 200 nucleotides which cannot be translated into proteins. Small nucleolar RNA host gene 15 (SNHG15) is a lncRNA whose dysregulation has been found to have an important impact on carcinogenesis and affect the prognosis of cancer patients in various cancer types. Hepatocellular carcinoma (HCC) is one of the most common cancers with a poor long-term prognosis, while the best prognostic factor of the disease is its early diagnosis and surgery. Consequently, the investigation of the mechanisms of hepatocarcinogenesis, as well as the discovery of efficient molecular markers and therapeutic targets are of great significance. An extensive literature search was performed in MEDLINE in order to identify clinical studies that tried to reveal the role of SNHG15 in HCC. We used keywords such as 'HCC', 'hepatocellular carcinoma', 'SNHG15' and 'clinical study'. Finally, we included four studies written in English, published during the period 2016-2021. It was revealed that SNHG15 is related to the appearance of HCC via different routes and its over-expression affects the overall survival of the patients. More assays are required in order to clarify the potential role of SNHG15 as a prognostic tool and therapeutic target in HCC.
Keywords: SNHG15; cancer; carcinoma; hepatocarcinogenesis; hepatocellular; lncRNA.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Dimitroulis D., Damaskos C., Valsami S., Davakis S., Garmpis N., Spartalis E., Athanasiou A., Moris D., Sakellariou S., Kykalos S., et al. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. World J. Gastroenterol. 2017;23:5282–5294. doi: 10.3748/wjg.v23.i29.5282. - DOI - PMC - PubMed
-
- Garmpis N., Damaskos C., Garmpi A., Georgakopoulou V.E., Sarantis P., Antoniou E.A., Karamouzis M.V., Nonni A., Schizas D., Diamantis E., et al. Histone deacetylase inhibitors in the treatment of hepatocellular carcinoma: Current evidence and future opportunities. J. Pers. Med. 2021;11:223. doi: 10.3390/jpm11030223. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
